Chinese PD-LRRK2 Registry
Recruiting · NCT03523104 · Observational (researchers observe without assigning treatment) · Lead sponsor: Xiangya Hospital of Central South University
View the official record on ClinicalTrials.gov →What this trial is about
The purpose of the Chinese PD-LRRK2 Registry(CPD-LRRK2R) is to develop a database of patients of Parkinson's disease with leucine-rich repeat kinase 2 (LRRK2) gene variants in mainland China.
Who can take part
Age range
No age limits stated
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)
Inclusion criteria
- Patients diagnosed with PD by the United Kingdom Parkinson's Disease Society Brain Bank clinical diagnostic criteria or other standard criteria; PD patients detected with positive LRRK2 variants
Where it is running
1 location listed.
- Xiangya Hospital of Central South University - Changsha, Hunan, China